IFN-γ promotes expression of PD-L1 and PD-L2 not only in tumor cells, but also in other stromal cells including immune infiltrating cells, and suppresses the effector function of tumor-specific T cells or NK cells through an interaction with an immune inhibitory receptor, PD-1 [84,85,86]. The gene discussed is PDCD1LG2; the disease is neoplasm.